These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30879543)

  • 1. Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.
    Ezzitouny M; Sánchez-Lázaro I; Rivera M; Portolés-Sanz M; Roselló-Lletí E; Gil-Cayuela C; Almenar-Bonet L; López-Vilella R; Ferré-Vallverdú M; Sanz-Sánchez J; Cerveró-Rubio A; Jiménez-Aguilella JJ; Pérez-Roselló V; Donoso-Trenado V; Arenas-Martín P; Lozano-Edo S; Jover-Pastor P; Martínez-Dolz L
    Transplant Proc; 2019 Mar; 51(2):369-371. PubMed ID: 30879543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.
    Lozano-Edo S; Sánchez-Lázaro I; Almenar-Bonet L; Portolés M; Ezzitouny M; Tarazón E; Roselló-Lleti E; Lopez-Vilella R; Martínez-Dolz L
    Transplant Proc; 2021 Nov; 53(9):2718-2720. PubMed ID: 34674882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end product accumulation in the cardiomyocytes of heart failure patients with and without diabetes.
    Nożyński J; Zakliczyński M; Konecka-Mrowka D; Zielinska T; Zakliczynska H; Nikiel B; Mlynarczyk-Liszka J; Mrowka A; Zembala-Nozynska E; Pijet M; Rdzanowska K; Lange D; Przybylski R; Zembala M
    Ann Transplant; 2012; 17(2):53-61. PubMed ID: 22743723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes.
    Cortés R; Roselló-Lletí E; Rivera M; Martínez-Dolz L; Salvador A; Azorín I; Portolés M
    Cardiovasc Res; 2010 Feb; 85(3):464-72. PubMed ID: 19819881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
    Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Salvador A; Rivera M
    Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes.
    Tarazón E; Rivera M; Roselló-Lletí E; Molina-Navarro MM; Sánchez-Lázaro IJ; España F; Montero JA; Lago F; González-Juanatey JR; Portolés M
    PLoS One; 2012; 7(11):e48957. PubMed ID: 23152829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
    Lee S; Lu R; Müller-Ehmsen J; Schwinger RH; Brixius K
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1134-8. PubMed ID: 20804510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
    Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure entails significant changes in human nucleocytoplasmic transport gene expression.
    Molina-Navarro MM; Roselló-Lletí E; Tarazón E; Ortega A; Sánchez-Izquierdo D; Lago F; González-Juanatey JR; García-Pavía P; Salvador A; Montero JA; Portolés M; Rivera M
    Int J Cardiol; 2013 Oct; 168(3):2837-43. PubMed ID: 23651824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
    Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
    BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of heart transplantation patients with ischemic and idiopathic dilated cardiomyopathy.
    Gungor H; Oguz E; Ayik MF; Ertugay S; Engin C; Yagdi T; Nalbantgil S; Zoghi M; Ozbaran M
    Transplant Proc; 2011 Dec; 43(10):3847-50. PubMed ID: 22172858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.
    Marini C; Giorgetti A; Gimelli A; Kusch A; Sereni N; L'abbate A; Marzullo P; Sambuceti G
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):682-8. PubMed ID: 15747157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy.
    Kozdag G; Ciftci E; Ural D; Sahin T; Selekler M; Agacdiken A; Demirci A; Komsuoglu S; Komsuoglu B
    Vasc Health Risk Manag; 2008; 4(2):463-9. PubMed ID: 18561522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial ischemia in patients with dilated cardiomyopathy.
    Fang W; Zhang J; He ZX
    Nucl Med Commun; 2010 Nov; 31(11):981-4. PubMed ID: 20808261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?
    Hsich EM; Rogers JG; McNamara DM; Taylor DO; Starling RC; Blackstone EH; Schold JD
    JACC Heart Fail; 2016 Sep; 4(9):689-97. PubMed ID: 27179836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.